🇺🇸 FDA
Patent

US 7700128

Solid preparation comprising an insulin sensitizer, an insulin secretagogue and a polyoxyethylene sorbitan fatty acid ester

granted A61KA61K31/4439A61K31/64

Quick answer

US patent 7700128 (Solid preparation comprising an insulin sensitizer, an insulin secretagogue and a polyoxyethylene sorbitan fatty acid ester) held by Takeda Pharmaceutical Company Limited expires Mon Apr 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Apr 20 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K31/4439, A61K31/64, A61K45/06, A61K9/2077